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Summary. Major advances have been made in 
understanding the role of telomerase in cellular 
immortalization and carcinogenesis. Human telomeres 
undergo progressive shortening with cell division, and 
critical shortening of telomeres with cellular aging 
triggers a signal for cells to stop dividing and senesce. 
Telomerase is an enzyme that adds telomeric-repeated 
sequences to the ends of human chromosome DNA. 
Telomerase is active in the vast majority of tumors, but 
not in normal somatic tissues, and prevents progressive 
shortening of telomeres with cell division, probably 
giving tumor cells a growth advantage over normal cells. 
Highly-sensitive PCR-based TRAP (telomeric repeat 
amplification protocol) assay provided the means to 
analyze telomerase in a wide variety of tissues. Evidence 
has been accumulated that this assay may be useful as a 
potential diagnostic tool for cancer. The constituents of 
telomerase complex have recently been identified, and 
human telomerase reverse transcriptase (hTERT) has 
been found to be responsible for the enzymatic activity 
of telomerase. Detection of hTERT mRNA may 
therefore be useful for the screening and diagnosis of 
cancers. The mechanisms regulating hTERT expression 
have been extensively analyzed, and transcriptional 
regulation of hTERT has been found to be essential for 
hTERT expression, in which several nuclear factors 
including c-Myc play crucial roles. Understanding of 
such mechanisms might provide insight into molecular 
basis of human carcinogenesis and contributes to the 
development of novel cancer gene therapy targeting 
telomerase. 
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The roles of telomeres and telornerase in cellular 
aging 
Normal cells have limited proliferative capacity. 
After a definite number of cell divisions, normal cells 
stop dividing and attain their finite life span. This 
process is referred to as cellular aging or senescence. In 
contrast, most malignant tumor cells have an infinite life 
span and continue to proliferate until their host dies. 
Normal cells are thus thought to have a so-called 
endogenous mitotic clock by which they recognize how 
many times they have divided. This clock is probably 
inactive in tumor cells. Recent progress in research in 
cellular aging has revealed that the DNA structures 
located at the ends of chromosomes, called telomeres, 
play essential roles in mechanisms of cellular aging. 
Telomeres are the distal ends of eukaryotic 
chromosomes, and are composed of an average of 5000- 
15000 base pairs of (7TAGGG)n repeats and telomere 
binding proteins (Moyzis et al., 1988). It has been 
suggested that one of the major functions of telomeres is 
stabilization of chromosomes (Blackburn, 1991). In 
yeast, it has been shown that removal of the telomere of 
a nonessential chromosome causes dramatic loss of that 
chromosome (Sandell and Zakian, 1993). It remains 
unclear how telomeric structures contribute to 
chromosomal stability, but they may effectively shield 
chromosomal ends from exonuclease digestion and 
prevent aberrant recombination. 
DNA polymerase is an enzyme that copies the 
s trands of DNA prior to cell division by base 
polymerization in the 5' to 3' direction. However, it fails 
to fully replicate the ends of linear DNA templates 
(Watson, 1972). This failure is thought to be caused by 
the difference in replication mechanisms between 
leading and lagging strands. Fig. 1 shows the replication 
fork at which new strands of DNA are synthesized. As 
the replication fork proceeds, the lagging strands are 
synthesized as series of discrete fragments, termed 
Okazaki fragments, each requiring a new RNA primer to 
begin DNA polymerization. This is due to the inability 
of DNA polymerase to polymerize in the 3'  to 5 '  











